![FFG_Lexogen_Coronavirus_Blog Thumbnail](https://www.lexogen.com/wp-content/uploads/2020/04/FFG_Lexogen_Coronavirus_Blog-Thumbnail-300x201.png)
Lexogen Receives FFG Funding to Develop a Novel SARS-CoV-2 Test for Mass Screening
Vienna, Austria, April 29, 2020 – Lexogen GmbH, a Vienna based Next-Generation Sequencing (NGS) and transcriptomics company, receives funding from the Austria Research Promotion Agency (FFG) for the development of